Topic
cancer research
55 stories related to this topic, newest first.
Newsweekworld19 hrs ago
MIT Study: High-Fat Ketogenic Diet Increased Small-Intestine Tumors in Cancer-Prone Mice
Researchers at the Massachusetts Institute of Technology reported that a ketogenic diet increased tumor growth in the small intestines of cancer-prone mice. The effect was driven by dietary fat activating the PPAR-delta pathway rather than by ketone bodies. The study was publishe…
news.ycombinator.comworld3 days ago
Amphibian Bacterium Eliminated Bowel Cancer Tumors in Mice After One Dose
Researchers isolated Ewingella americana from amphibians and found a single intravenous dose eliminated tumors in mice. The study, published in Gut Microbes, showed dual action through direct cell killing and immune activation. The Independent reported the results from the Japan…
finance.yahoo.comscience4 days ago
Mouse study links B cells to immunotherapy response in glioblastoma
New research published in Science Immunology examined how B cells contribute to antitumor activity during immunotherapy treatment for glioblastoma in mice. The findings describe a specific cellular mechanism observed in the laboratory model.
SC
news.sky.comai4 days ago
Edinburgh Researchers Test AI Method to Spot Lung Cancer Gene Changes
Scientists at the University of Edinburgh and NHS Lothian created a fluorescence lifetime imaging method paired with artificial intelligence that identifies EGFR mutations in lung cancer tissue. The approach aims to replace slower, costlier gene sequencing tests. GB News reported…
jpost.comscience7 days ago
Study identifies immune proteins shielding cancer cells from T-cell attack
Research published in Science Signaling describes two signaling proteins that help cancer cells resist destruction by cytotoxic T cells. The proteins blunt the effects of interferon-γ, an inflammatory cytokine released during immune responses.
SC
nypost.comworld7 days ago
UCLA Study Links Creatine to Stronger Immune Response Against Tumors in Mice
Researchers at UCLA Health Sciences reported that creatine supported dendritic cells in activating cancer-fighting T cells in laboratory and mouse experiments. The findings do not show that creatine supplements improve outcomes for cancer patients. Further human studies are requi…
english.elpais.comscience8 days ago
Study Identifies Tumor-to-Nerve Pathway Driving Cancer Cachexia in Mice
A new study in mice found a pathway connecting lung tumor genetics, diet, and the nervous system that contributes to cancer-associated cachexia. The research points to a potential therapeutic target for the wasting condition.
SC
israelnationalnews.comworld13 days ago
Tel Aviv University Researchers Identify How Tumors Redirect Immune Cells
A Tel Aviv University study found that tumors can reprogram macrophages, immune cells that normally clear dead tissue, to support cancer growth instead. The work introduces a new tracking method and links the changes to faster tumor expansion and lower patient survival rates.
JE
neurosciencenews.comscience25 days ago
Study Links Accelerated Biological Aging to Higher Early-Onset Cancer Risk
A study published in Nature Medicine examined data from two large cohorts and found that people born in later decades showed greater biological aging than earlier cohorts. This accelerated aging was associated with increased risk of several early-onset solid cancers.
ER
newscientist.comscience28 days ago
Pancreatic Cancer Drug Extends Survival in International Study
An international study presented May 31 reported longer survival for pancreatic cancer patients taking daraxonrasib. The FDA granted early access to the drug one month earlier for selected patients.
rove.meworld28 days ago
South African Researchers Map Cancer-Related Changes to MUC1 Protein
A University of Cape Town team used computational models and test-tube experiments to trace how cancer cells alter the MUC1 protein. The study, published in Nature Communications, shows the relocation of sugar-building enzymes inside tumor cells.
marketwatch.comscience32 days ago
Elicio Shares Fall After Pancreatic Cancer Vaccine Misses Mid-Stage Primary Endpoint
Elicio shares declined after its pancreatic cancer vaccine failed to meet primary and key efficacy endpoints in a mid-stage clinical trial, according to @Reuters reported.
prnewswire.comscience32 days ago
Study Describes Method to Track Macrophage Response to Tumor Cell Clearance
A laboratory method called Effero-seq was used in mouse melanoma models. The approach recorded changes in macrophages after they cleared tumor cells.
SC
The Independentscience39 days ago
Oxford University and Moderna to begin cancer vaccine trials this summer
A vaccine developed by Oxford University and Moderna will enter clinical testing this summer in patients with Lynch syndrome. The trial will assess whether the mRNA shot can train the immune system to destroy pre-cancerous cells before tumors form.
zmescience.comscience39 days ago
Johnson & Johnson to Acquire KRAS Startup Firefly Bio for $1 Billion After Recent Pancreatic Cancer Data Validates Field
The acquisition targets KRAS inhibitors after Revolution Medicines reported nearly doubled survival in metastatic pancreatic cancer less than two months earlier.
The Guardianscience40 days ago
New Pancreatic Cancer Drug Doubles Survival Time in Trial
A daily pill extended median survival from 6.5 to 13.5 months for patients with advanced pancreatic cancer in a 500-person study. Separate early trials showed a smart drug shrank tumors in six common cancers, and observational data linked GLP-1 weight-loss drugs to lower cancer r…
The Guardianscience40 days ago
Australian Melanoma Researcher Richard Scolyer Dies at 59 After Experimental Glioblastoma Treatment
Professor Richard A Scolyer, joint 2024 Australian of the Year, died on 7 June 2026 after a three-year battle with glioblastoma. He left an open letter urging continued investment in brain cancer research.
Los Angeles Timesscience41 days ago
California Researchers Launch $12.5 Million Nationwide Study of Cancer Patterns in Asian Americans
UCSF and partner institutions will track 20,000 participants to examine rising lung and breast cancer rates. The ASPIRE Cohort is the first large-scale longitudinal study focused on this population.
Statscience42 days ago
Patient Reports Benefit from Revolution Medicines’ Daraxonrasib as Oncologists Applaud Data but Biotech Stocks Fall
Leanna Stokes, diagnosed with metastatic pancreatic cancer in 2023, discussed her experience in a Revolution Medicines clinical trial on a June 4, 2026 podcast. Oncologists gave a standing ovation to data on the company’s drug daraxonrasib presented at last week’s American Societ…
thequint.comscience42 days ago
Large NCI-Funded Phase 3 Trial Tests Probiotic CBM588 With Immunotherapy in Advanced Kidney Cancer
A multicenter study funded by the National Cancer Institute will test whether CBM588 improves outcomes when taken with immunotherapy in nearly 700 people with advanced renal cell carcinoma.
Substrate placeholder — needs reviewworld44 days ago
Small Phase-2 Trial Finds 85% of Bladder Cancer Patients Cancer-Free at One Year With Added Immunotherapy
A phase-two study found that adding durvalumab to chemotherapy and radiotherapy kept cancer from returning in 46 of 54 patients. The approach may allow some patients to avoid bladder removal surgery.
Nbc Newsworld46 days ago
Personalized mRNA Vaccine Shows Reduced Melanoma Recurrence in Small Phase 2 Trial
A Moderna and Merck experimental vaccine cut melanoma recurrence risk by half in a five-year trial. Results were presented June 1, 2026, at the American Society of Clinical Oncology meeting.
GB Newsworld46 days ago
Canadian Researcher With Stage Four Cancer Reaches Everest Summit
Dr Shaunna Burke reached the summit at 3 a.m. on May 23 while managing terminal breast cancer and chemotherapy, raising funds for Macmillan Cancer Support.
fortune.compolitics47 days ago
Drug Doubles Survival in Metastatic Pancreatic Cancer Trial
An international trial presented Sunday showed daraxonrasib doubled median survival for patients with metastatic pancreatic cancer compared with standard chemotherapy. France has expanded a personalized screening program to eight additional centers.
Science Newsworld46 days agoUpdated
Pill Nearly Doubles Survival Time in Pancreatic Cancer Trial
A once-daily pill nearly doubled average survival for patients with advanced pancreatic cancer in a 500-patient randomized study. Patients on the drug lived 13.2 months on average versus 6.6 months on chemotherapy.
science48 days ago
Amivantamab Shows Tumor Response in 43 of 102 Patients With Advanced Head and Neck Cancer
An 11-nation trial of the Johnson & Johnson drug showed tumor shrinkage in more than a third of patients whose disease had returned or spread. Median survival reached 12.5 months after treatment began.
The Guardianscience48 days ago
Amivantamab Shows Tumor Responses in 43 of 102 Patients with Advanced Head and Neck Cancer
An international trial found the Johnson & Johnson drug shrank or eliminated tumors in 43 of 102 patients whose disease had resisted prior chemotherapy and immunotherapy. Results will be presented Sunday at the American Society of Clinical Oncology meeting in Chicago.
freepressjournal.inscience49 days ago
Lung cancer in never-smokers recognized as distinct disease
Medical researchers now classify lung cancer in people who have never smoked as a separate condition. The classification includes dedicated treatments and prevention approaches.
NA
sixthtone.comworld49 days ago
Pancreatic cancer treatment advance prompts pharmaceutical deal activity
A recent medical advance in pancreatic cancer treatment has led to increased dealmaking among pharmaceutical companies. The development follows years of limited progress in the disease area.
prweb.comscience55 days ago
Study Examines How Anti-PD-1 Antibodies Affect Immune Cell Signaling
A new study published in Science Immunology reports that anti-PD-1 antibodies trap PD-1 proteins at nanoscale immune contacts and trigger inhibitory checkpoint signaling. The findings identify potential targets for improving immunotherapy design.
SC
Statscience57 days ago
Merck-Kelun Drug Reduced Lung Cancer Progression Risk by 65 Percent in Trial
Phase 3 study results showed that a targeted chemotherapy developed by Kelun-Biotech and licensed to Merck reduced tumor progression risk by 65 percent in patients with advanced non-small cell lung cancer. A preliminary survival benefit was observed but requires longer follow-up…
Euronewsworld58 days ago
Study Detects Cancer-Causing Viruses in Texas Wastewater Samples
Researchers identified major oncogenic viruses in wastewater from 16 Texas cities. The findings could support future public health monitoring of infection trends.
Fox Newsscience58 days ago
Merck Drug Sac-TMT Meets Survival Goals in Endometrial Cancer Trial
Merck announced Monday that its investigational drug sacituzumab tirumotecan met primary survival endpoints in a Phase 3 trial for advanced or recurrent endometrial cancer. The TroFuse-005 study compared the drug to physician-chosen chemotherapy in 776 patients.
Science Newsscience59 days ago
Damaged DNA Travels Between Human Cells via Nanotubes
Researchers observed DNA fragments moving from one human cell to another through tunneling nanotubes after genome damage. The study, published May 19 in Cell, shows the transferred DNA can carry functional genes.
ncbi.nlm.nih.govscience61 days ago
Study Shows Heartbeat Limits Tumor Growth in Cardiac Tissue
A Science study reports that the mechanical forces from constant heart contractions alter gene regulation in cancer cells. The research examines how these forces may prevent tumor development in heart tissue.
SC
nbcnews.comworld61 days ago
Study Links Grey Hair in Mice to Cellular Process
A new mouse study examined how melanocyte stem cells respond to DNA damage. Researchers found that certain damage types trigger a process leading to grey hair while removing potentially cancerous cells.
IN
Fox Newsscience63 days ago
Small University of Rochester Trial Finds Modest Cognitive Benefits From Exercise and Ibuprofen During Chemotherapy
A phase 2 trial of 86 cancer patients undergoing chemotherapy showed that a six-week home exercise program produced the clearest gains in attention and cognitive function. Low-dose ibuprofen alone also yielded greater cognitive improvements than placebo. Researchers cautioned tha…
ncbi.nlm.nih.govscience65 days ago
Androgen Loss Accelerates Brain Tumour Growth in Mouse Models
A research paper reports that androgen deprivation via castration speeds intracranial tumour growth in mice with glioblastoma while slowing extracranial tumours. The study links the effect to elevated glucocorticoids, systemic T cell dysfunction and an immunosuppressive tumour mi…
NA
scienceblog.cancerresearchuk.orgworld70 days ago
Cancer Research UK Closes Aberdeen Store as Part of 190-Shop Reduction Plan
Cancer Research UK closed its Aberdeen branch on Rosemount Viaduct on May 8, 2026, as the first wave of 90 permanent store closures scheduled for completion by the end of the month. The charity announced the restructuring programme in October 2025, citing rising costs, declining…
medium.comai71 days ago
Machine-Learning Analysis Identifies Nine Conserved Spatial Ecotypes Across Human Tumors
Researchers integrated more than 10 million single-cell and spot-level spatial transcriptomes from diverse human carcinomas and melanomas to define nine spatial ecotypes. Each ecotype shows unique biology, geospatial features and clinical outcome associations, including links to…
NA
link.springer.comai72 days ago
Machine Learning Framework Identifies Tumor Microenvironment Ecotypes in Blood Samples
Researchers developed a machine learning approach that identifies nine spatial ecotypes in the tumor microenvironment from over 10 million single-cell and spatial transcriptomes across multiple cancer types. The ecotypes can be detected noninvasively through cell-free DNA methyla…
ER
deadline.comworld81 days ago
Polish Streamer Łatwogang Raises Over $70 Million for Childhood Cancer in 9-Day Broadcast
Polish streamer Łatwogang completed a 9-day live broadcast that raised more than 250 million złoty, equivalent to about $70 million, for childhood cancer patients. The event, which ended yesterday, set a new world record for charity fundraising during a live stream. @MarioNawfal…
MA
Substrate placeholder — needs reviewscience82 days ago
Heart Beating Inhibits Cancer Growth in Mice, Study in Science Reveals
A new study published today in Science shows that the mechanical beating of the heart prevents cancer cells from proliferating in mouse hearts. Researchers transplanted non-beating hearts and observed rapid cancer growth compared to native beating hearts. This finding may explain…
NA
fortune.comscience83 days ago
Mouse Study Finds Heart's Mechanical Stress May Inhibit Cancer Metastasis
Researchers in Italy published a study in Science suggesting that the heart's constant beating creates a hostile environment for cancer cells. The work, conducted in mice, identified genetic mechanisms and a protein that senses mechanical forces. Experts called the findings hypot…
ecns.cnscience84 days ago
Researchers Identify GPX4 Inhibitors That Target Senescent Cells in Cancer Models
A study has identified GPX4 inhibitors that selectively kill senescent cells, which accumulate in tumors after chemotherapy. These compounds showed effectiveness in preclinical models of melanoma, prostate, and ovarian cancer. The findings suggest a potential new strategy for can…
ER
ndtv.comscience85 days ago
Mouse Study Finds Heart's Mechanical Stress May Suppress Cancer Growth
Researchers published a study in Science suggesting that the heart's constant beating creates an environment hostile to cancer. The work, conducted in mice, identified genetic mechanisms linked to mechanical forces. Experts called the findings hypothesis-generating and pointed to…
Substrate placeholder — needs reviewscience86 days ago
Revolution Medicines Presents Strong KRAS Drug Data and Preclinical Compound Insights
Revolution Medicines shared clinical trial success for its pancreatic cancer therapy last week and preclinical data on a new compound yesterday. The company also presented strong results for its KRAS drug at the AACR meeting on April 21, 2026. Additional biotech developments incl…
ST
Opabinia regalis / Wikimedia (CC BY-SA 4.0)science86 days ago
Study Reveals EBV Variant and Host Gene Interaction as Key Driver of Nasopharyngeal Carcinoma Risk
Researchers identified a genetic interaction between a high-risk Epstein-Barr virus variant and specific host HLA alleles that significantly elevates nasopharyngeal carcinoma risk in southern China. The findings, published in Nature, highlight a dual-risk subgroup accounting for…
NA
Substrate placeholder — needs reviewfinance89 days ago
Sutro Biopharma Presents Preclinical Data on ADC Programs at AACR 2026
Sutro Biopharma announced preclinical data for its antibody drug conjugate programs at the American Association for Cancer Research Annual Meeting 2026. The data covered STRO-004 and other next-generation ADCs, showing antitumor activity in solid tumor models. Initial Phase 1 stu…
Substrate placeholder — needs reviewscience92 days ago
Giant Cancer Study Evaluates Effectiveness of Off-Label Treatments
A recent study has assessed the effectiveness of off-label cancer treatments, revealing significant findings. The research highlights the potential benefits and risks associated with these therapies.
NA
National Institutes of Health. / Wikimedia (Public domain)science94 days ago
Researchers Develop AI Method to Identify Bevacizumab Responders in Advanced Bowel Cancer
Scientists at the Institute of Cancer Research in London and RCSI University of Medicine and Health Sciences in Dublin have developed an AI tool to predict which patients with advanced bowel cancer will benefit from bevacizumab. The method, published in Scientific Reports, analyz…
Substrate placeholder — needs reviewscience95 days ago
Study Finds Young Adult Cancer Survivors Face Double Risk of Subsequent Cancers
A study published in the Canadian Medical Association Journal analyzed data from Alberta cancer survivors diagnosed between ages 15 and 39 from 1983 to 2017. The research showed these survivors are twice as likely to develop new cancers compared to the general population. Experts…
Substrate placeholder — needs reviewscience95 days ago
GSK Presents Early-Stage Data on Experimental Cancer Drug and Plans Five Phase 3 Trials
GSK presented data from an early-stage clinical trial of an experimental cancer drug over the weekend. The company stated that the results support advancing the drug to five Phase 3 trials this year. This development follows initial testing to evaluate the drug's safety and preli…
ST
Substrate placeholder — needs reviewscience97 days ago
Lung Cancer Rates Rise Among Nonsmoking Asian American and Latina Women Amid Limited Screening Access
A 2023 study reported that lung cancer rates among nonsmoking Asian American women increased by 2 percent annually from 2007 to 2018, while rates decreased in other groups. Federal screening guidelines limit coverage for low-dose CT scans to individuals aged 50 to 80 with signifi…
Substrate placeholder — needs reviewscience100 days ago
Recent Health News Highlights Breakthrough in Duchenne Treatment and Insulin Price Cap
A new therapy shows promise for Duchenne muscular dystrophy patients. Insulin prices are capped at $35 for many users. Additional evidence supports over-the-counter availability of abortion medications.
ST